S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q3 2025

RA Capital Management

Period: Q3 2025 Β· Filed: 2025-11-14
View on SEC EDGAR β†—
AUM
$8.12B
Total portfolio value
Positions
67
Reported securities
Top Holding
ASND
25.2% $2.04B
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S - ADR$2.04B25.19%$198.81$274.50+38.1%
25.2%
RYTMRHYTHM PHARMACEUTICALS INC$573.8M7.07%$100.99$114.17+13.1%
7.1%
PCVXVAXCYTE INC$431.0M5.31%$36.02$58.39+62.1%
5.3%
RNAMAVIDITY BIOSCIENCES INC$376.5M4.64%β€”β€”
4.6%
CDTXCIDARA THERAPEUTICS INC$322.3M3.97%β€”β€”
4.0%
SIONSIONNA THERAPEUTICS INC$307.2M3.79%$29.41$43.99+49.6%
3.8%
ETNB89BIO INC$292.4M3.60%β€”β€”
3.6%
NAMSNEWAMSTERDAM PHARMA CO NV$288.4M3.55%$28.44$34.83+22.5%
3.5%
MLYSMINERALYS THERAPEUTICS INC$277.7M3.42%$37.92$27.69-27.0%
3.4%
JANXJANUX THERAPEUTICS INC$273.5M3.37%$24.44$15.54-36.4%
3.4%
ACLXARCELLX INC$249.3M3.07%$82.10β€”
3.1%
LENZLENZ THERAPEUTICS INC$194.7M2.40%$46.58$5.89-87.4%
2.4%
TYRATYRA BIOSCIENCES INC$170.7M2.10%$13.99$30.62+118.9%
2.1%
EWTXEDGEWISE THERAPEUTICS INC$169.2M2.08%$16.22$39.56+143.9%
2.1%
WVEWAVE LIFE SCIENCES LTD$133.2M1.64%$7.32$6.26-14.5%
1.6%
SEPNSEPTERNA INC$131.6M1.62%$18.81$34.00+80.8%
1.6%
DNTHDIANTHUS THERAPEUTICS INC$112.8M1.39%$39.35$94.34+139.8%
1.4%
BCAXBICARA THERAPEUTICS INC$109.8M1.35%$15.79$29.00+83.7%
1.4%
GHRSGH RESEARCH PLC$109.8M1.35%$14.30$27.01+88.9%
1.4%
SPRYARS PHARMACEUTICALS INC$109.2M1.34%$10.05$8.56-14.8%
1.3%
NUVLNUVALENT INC-A$107.8M1.33%$86.48$123.73+43.1%
1.3%
IRONDISC MEDICINE INC$104.2M1.28%$66.08$76.26+15.4%
1.3%
VORVOR BIOPHARMA INC$96.6M1.19%$48.72$20.59-57.7%
1.2%
FULCFULCRUM THERAPEUTICS INC$94.1M1.16%$9.20$3.84-58.3%
1.2%
PEPGPEPGEN INC$92.7M1.14%$4.62$1.76-61.9%
1.1%
GERNGERON CORP$82.7M1.02%$1.37$1.36-0.7%
1.0%
TSHATAYSHA GENE THERAPIES INC$77.0M0.95%$3.27$6.53+99.7%
0.9%
BLTEBELITE BIO INC - ADR$64.8M0.80%$74.00$146.63+98.2%
0.8%
CLYMCLIMB BIO INC$63.1M0.78%$2.01$12.90+541.8%
0.8%
SRRKSCHOLAR ROCK HOLDING CORP$43.5M0.54%$37.24$54.88+47.4%
0.5%

Quarter-on-Quarter Activity

Q3 2025 vs. Q2 2025

New Positions (8)

TickerIssuerNotionalSince Filing
NUVLNUVALENT INC-A$107.8M+43.1%
VORVOR BIOPHARMA INC$96.6M-57.7%
BLTEBELITE BIO INC - ADR$64.8M+98.2%
LBRXLB PHARMACEUTICALS INC$28.1M
ASMBASSEMBLY BIOSCIENCES INC$26.1M
CTNMCONTINEUM THERAPEUTICS INC-A$24.9M
IVVDINVIVYD INC$18.8M
PRMEPRIME MEDICINE INC$16.6M

Exited Positions (8)

TickerIssuerNotional
DYNDYNE THERAPEUTICS INC$92.5M
VORXXXXVOR BIOPHARMA INC$64.2M
RXSTRXSIGHT INC$48.1M
TRMLTOURMALINE BIO INC$40.6M
ELVNENLIVEN THERAPEUTICS INC$17.0M
HNGEHINGE HEALTH INC-A$15.5M
OMDAOMADA HEALTH INC$7.3M
BBNXBETA BIONICS INC$7.3M

Increased (7)

TickerIssuerNotionalShares Ξ”Since Filing
PEPGPEPGEN INC$80.8M+87.7%-61.9%
MLYSMINERALYS THERAPEUTICS INC$194.5M+19.1%-27.0%
RNAMAVIDITY BIOSCIENCES INC$170.1M+18.9%
EWTXEDGEWISE THERAPEUTICS INC$39.3M+5.3%+143.9%
SRRKSCHOLAR ROCK HOLDING CORP$3.2M+2.7%+47.4%
RYTMRHYTHM PHARMACEUTICALS INC$222.3M+2.2%+13.1%
SLDBSOLID BIOSCIENCES INC$7.6M+0.0%

Trimmed (1)

TickerIssuerNotionalShares Ξ”
AVTXAVALO THERAPEUTICS INC$3.8M-28.9%
← Back to Hedge Funds